Eli Lilly Financials

LLY Stock  EUR 746.10  5.70  0.76%   
We urge to utilize Eli Lilly fundamental analysis to see if markets are presently undervaluing or overvaluing the company. Put another way, this technique allows you to check available reported financial drivers of Eli Lilly as well as the relationship between them. We have analyzed and interpolated fourteen available fundamental indicators for Eli Lilly and, which can be compared to its peers. The stock experiences a moderate downward daily trend and can be a good diversifier. Check odds of Eli Lilly to be traded at €731.18 in 90 days.
  
Understanding current and past Eli Lilly Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Eli Lilly's financial statements are interrelated, with each one affecting the others. For example, an increase in Eli Lilly's assets may result in an increase in income on the income statement.
Foreign Associates
InstrumentGermany Stock View All
ExchangeHamburg Exchange
SectorOther
IndustryOther
BenchmarkDow Jones Industrial
CurrencyEUR - Euro
You should never invest in Eli Lilly without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Eli Stock, because this is throwing your money away. Analyzing the key information contained in Eli Lilly's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Eli Lilly Key Financial Ratios

There are many critical financial ratios that Eli Lilly's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Eli Lilly reports annually and quarterly.

Eli Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eli Lilly's current stock value. Our valuation model uses many indicators to compare Eli Lilly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eli Lilly competition to find correlations between indicators driving Eli Lilly's intrinsic value. More Info.
Eli Lilly and is considered the number one company in current valuation category among its peers. It is rated second overall in price to book category among its peers . The ratio of Current Valuation to Price To Book for Eli Lilly and is about  9,628,269,936 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eli Lilly's earnings, one of the primary drivers of an investment's value.

Eli Lilly Systematic Risk

Eli Lilly's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eli Lilly volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Eli Lilly correlated with the market. If Beta is less than 0 Eli Lilly generally moves in the opposite direction as compared to the market. If Eli Lilly Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eli Lilly is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eli Lilly is generally in the same direction as the market. If Beta > 1 Eli Lilly moves generally in the same direction as, but more than the movement of the benchmark.

Eli Lilly November 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Eli Lilly help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eli Lilly and. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eli Lilly and based on widely used predictive technical indicators. In general, we focus on analyzing Eli Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eli Lilly's daily price indicators and compare them against related drivers.

Additional Information and Resources on Investing in Eli Stock

When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.